Literature DB >> 17030646

Photodynamic therapy in oncology.

Martijn Triesscheijn1, Paul Baas, Jan H M Schellens, Fiona A Stewart.   

Abstract

Photodynamic therapy (PDT) is increasingly being recognized as an attractive, alternative treatment modality for superficial cancer. Treatment consists of two relatively simple procedures: the administration of a photosensitive drug and illumination of the tumor to activate the drug. Efficacy is high for small superficial tumors and, except for temporary skin photosensitization, there are no long-term side effects if appropriate protocols are followed. Healing occurs with little or no scarring and the procedure can be repeated without cumulative toxicity. Considering the efficacy and lack of long-term toxicity of PDT, and the fact that the first treatment of cancer with PDT was done more than 100 years ago, one might expect that this treatment had already become an established therapy. However, PDT is currently offered in only a few selected centers, although it is slowly gaining acceptance as an alternative to conventional cancer therapies. Here, we show the developmental steps PDT underwent and summarize the current clinical applications. The data show that, when properly used, PDT is an effective alternative treatment option in oncology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030646     DOI: 10.1634/theoncologist.11-9-1034

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  113 in total

Review 1.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

2.  Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment.

Authors:  R Ghoodarzi; V Changizi; A R Montazerabadi; N Eyvazzadaeh
Journal:  Lasers Med Sci       Date:  2015-12-21       Impact factor: 3.161

3.  Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.

Authors:  Daniela Meier; Carmen Campanile; Sander M Botter; Walter Born; Bruno Fuchs
Journal:  J Vis Exp       Date:  2014-03-18       Impact factor: 1.355

Review 4.  Malignant central airway obstruction.

Authors:  Lakshmi Mudambi; Russell Miller; George A Eapen
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

Authors:  Shaojuan Zhang; Ningyang Jia; Pin Shao; Qin Tong; Xiang-Qun Xie; Mingfeng Bai
Journal:  Chem Biol       Date:  2014-02-27

Review 6.  Recent advances in photodynamic therapy for cancer and infectious diseases.

Authors:  Xutong Shi; Can Yang Zhang; Jin Gao; Zhenjia Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-05-06

7.  Enhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurement.

Authors:  Sandra L Pena Luengas; Gustavo Horacio Marin; Kevin Aviles; Ricardo Cruz Acuña; Gustavo Roque; Felipe Rodríguez Nieto; Francisco Sanchez; Adrián Tarditi; Luis Rivera; Eduardo Mansilla
Journal:  Cancer Biother Radiopharm       Date:  2014-12       Impact factor: 3.099

8.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

9.  Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.

Authors:  Zhong-sheng Tong; Pei-tian Miao; Ting-ting Liu; Yong-sheng Jia; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

10.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.